Global Nasal Drug Delivery Market, By Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, Others), Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels and Ointments, Nasal Powders, Others), Container Type (Non-Pressurized Containers, Pressurized Containers), System Type (Multi-Dose, Bi-Dose, Unit Dose), Therapeutic Application (Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Clinics, Home Care Settings) – Industry Trends and Forecast to 2030.
Nasal Drug Delivery Market Analysis and Size
The rising patient preference for nasal drug delivery as a result of easy administration and better efficiency will act as major driver accelerating the global nasal drug delivery market’s growth rate. The rising adoption of self-administration practices will increase the demand for nasal drug delivery and further propel the market’s growth rate. Another significant factor resulting in the expansion of market is the rising focus on the development of smart/digital inhalers. Rapid urbanisation, changing lifestyle and rise in the level of disposable incomes in developing and developed countries will influence the growth rate of global nasal drug delivery market. The rise in the number of geriatric population and increase in the demand for home healthcare devices will flourish the growth rate of global nasal drug delivery market. Additionally, the increasing demand from emerging markets and the development of over-the-counter (OTC) drugs by various pharmaceutical companies will further expand the global nasal drug delivery market growth rate in the future.
Data Bridge Market Research analyses that the global nasal drug delivery market which was USD 61.20 billion in 2022, is expected to reach USD 102.80 million by 2030, and is expected to undergo a CAGR of 6.9% during the forecast period 2023-2030. This indicates that the market value. “Hospital” dominates the end-user segment of the global nasal drug delivery market owing to the wide range of products applications there. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Nasal Drug Delivery Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, Others), Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels and Ointments, Nasal Powders, Others), Container Type (Non-Pressurized Containers, Pressurized Containers), System Type (Multi-Dose, Bi-Dose, Unit Dose), Therapeutic Application (Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Clinics, Home Care Settings)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), AstraZeneca (U.K.), Johnson & Johnson (U.S.), Mystic Pharmaceuticals (U.S.), Bausch Health Companies Inc. (Canada), BD (U.S.), 3M (U.S.), AptarGroup, Inc. (U.S.), OptiNose US, Inc. (U.S.), Dr. Reddy’s Laboratories Ltd (India), Flo Nasal Products. (Australia), Cadila Pharmaceuticals (India), PendoPharm Inc. (Canada), Neurelis, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Nasal medication delivery is the process of delivering pharmaceuticals or drugs through the nasal passage. The technology's main advantages are its high effectiveness and efficiency in treating the target illnesses. Because it comprises a relatively streamlined and methodical technique of drug distribution, this mode of drug delivery is known to be a direct alternative to invasive modalities.
Global Nasal Drug Delivery Market Dynamics
Drivers
- Rise in the Patient Preference for Nasal Drug Delivery
One of the most popular drug delivery routes among patients and healthcare providers is intranasal drug delivery. This is due to the non-invasive nature of this mode of delivery and the fact that medication absorbability is higher via the nasal route.
- Increasing Adoption of Self-Administration Practices
Unlike some other methods of drug delivery, nasal drug delivery does not necessitate the use of a sterile method for introducing medications into the body. The ease with which these pharmaceuticals are administered is critical in enhancing patient adherence to drug regimens, which leads to better patient outcomes.
- Introduction of Off-patent Drugs for Respiratory Care
The development of generic inhalation drugs is being driven by the patent expiration of branded inhaled pharmaceuticals and increasing pressure on the healthcare budget. As the cost of treating asthma and COPD decreases, patients are more likely to become aware of DPIs and MDIs and use them.
Opportunity
- Increasing Easy Availability of Nasal Drugs
The easy availability of nasal drugs and growing attention on alternative routes such as nasal drug delivery is further provide potential opportunities for the growth of the nasal drug delivery technology market in the coming years. This will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.
Moreover, improvements in healthcare infrastructure in emerging markets have increased access to medical treatment, which will further expand the market and lead to the growth of the global nasal drug delivery market in the above mentioned projected timeframe.
Restraint/Challenge
- Rising Difficulties Regarding the Overuse of Nasal Sprays
On the other hand, the difficulties regarding the overuse of nasal sprays is further projected to impede the growth of the nasal drug delivery technology market in the targeted period. Moreover, the regulatory hurdles might further challenge the growth of the nasal drug delivery technology market in the forecast future. Moreover, this restraint lies in the need for rigorous clinical trials, safety assessments, and regulatory approvals for any new medication or therapy. These stringent processes can prolong the timeline and increase the costs associated with bringing innovative treatments to market, resulting in potential breakthrough treatments which are expected to become the biggest and foremost challenge for the growth of the market in the forecast period of 2023-2030.
This global nasal drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global nasal drug delivery market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In March 2021, Aptar Pharma and Noble, a subsidiary of Aptar Pharma, have established a partnership with dne pharma, a leader in addiction medicine in Northern Europe. The firms supply nasal drug delivery proficiency and training solutions for dne pharma's Ventizolve nasal naloxone to treat opioid overdose
- In February 2021, by establishing a non-exclusive agreement for formulation proof of concept projects, Nanoform Finland and Herantis announced their collaboration on nasal medicine delivery to the brain
Global Nasal Drug Delivery Market Scope
The global nasal drug delivery market is segmented on the basis of drug type, dosage form, container type, system type, therapeutic application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Type
- Anesthetics
- Antibiotics
- Pain Relief Drugs
- Calcium Supplements
- Vasoconstrictors
- Antihistamines
- Others
Dosage Form
- Nasal Spray
- Nasal Drops
- Nasal Gels and Ointments
- Nasal Powders
- Others
Container Type
- Non-Pressurized Containers
- Pressurized Containers
System Type
- Multi-Dose
- Bi-Dose
- Unit Dose
Therapeutic Application
- Allergic and Non-Allergic Rhinitis
- Nasal Congestion
- Asthma
- Vaccination
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
End User
- Hospitals
- Clinics
- Home Care Settings
Global Nasal Drug Delivery Market Regional Analysis/Insights
The global nasal drug delivery market is analysed and market size insights and trends are provided by country, drug type, dosage form, container type, system type, therapeutic application, distribution channel and end user as referenced above.
The countries covered in the global nasal drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global nasal drug delivery market due to the presence of major key players and well-established healthcare infrastructure in this region. Additionally, the increase in the prevalence of rhinitis, sinusitis, congestion and respiratory allergic reactions will further propel the market’s growth rate in this region.
Asia-Pacific is expected to expand at a significant growth rate during the forecast period of 2023 to 2030 due to the growing number of geriatric population and the rising incidences of allergy diseases in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global nasal drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global nasal drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global nasal drug delivery market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Nasal Drug Delivery Market Share Analysis
The global nasal drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global nasal drug delivery market.
Some of the major players operating in the global nasal drug delivery market are:
- Merck & Co., Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- AstraZeneca (U.K.)
- Johnson & Johnson (U.S.)
- Mystic Pharmaceuticals (U.S.)
- Bausch Health Companies Inc. (Canada)
- BD (U.S.)
- 3M (U.S.)
- AptarGroup, Inc. (U.S.)
- OptiNose US, Inc. (U.S.)
- Dr. Reddy’s Laboratories Ltd (India)
- Flo Nasal Products. (Australia)
- Cadila Pharmaceuticals (India)
- PendoPharm Inc. (Canada)
- Neurelis, Inc. (U.S.)
SKU-